Literature DB >> 8774489

Angiogenesis in normal, hyperplastic, and neoplastic endometrium.

K G Morgan1, N Wilkinson, C H Buckley.   

Abstract

The purpose of this study was to quantify vascular density in the stroma of normal, hyperplastic, and neoplastic endometria and to explore its relationship to other prognostic features of endometrioid adenocarcinoma. Curettage specimens of proliferative and mid-secretory endometrium; simple, complex, and atypical endometrial hyperplasia; and grade I endometrioid adenocarcinoma were stained with Factor VIII-related antigen. The number of vessels per mm2 of stroma was calculated for each case. The stroma of mid-secretory and hyperplastic endometrium was more vascular than that of proliferative endometrium. The stroma of adenocarcinoma, though reduced in proportion to the epithelium, was significantly more vascular than that of normal or hyperplastic endometrium. Stromal vascular density was not related to the depth of invasion, the presence of lymphovascular space permeation, or the state of the adjacent endometrium, whether atrophic or hyperplastic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774489     DOI: 10.1002/(SICI)1096-9896(199607)179:3<317::AID-PATH598>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Thymidine phosphorylase expression in normal and hyperplastic endometrium.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.

Authors:  E Sivridis; A Giatromanolaki
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

3.  The Expression of VEGF and CD31 in Endometrial Lesions and Its Associations with Blood Flow Parameters of Transvaginal 3D Power Doppler Ultrasonography: A Preliminary Study.

Authors:  Meijuan Liu; Li Cai; Qifan Li; Xiaoran Chen; Lingyun Gao; Lei Jiang
Journal:  Cancer Manag Res       Date:  2020-11-04       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.